share_log

Matinas BioPharma | 8-K: Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update

SEC ·  May 9 13:14
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more